The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.
about
Correlation versus causation? Pharmacovigilance of the analgesic flupirtine exemplifies the need for refined spontaneous ADR reportingDrug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase.Extraction of electronic health record data in a hospital setting: comparison of automatic and semi-automatic methods using anti-TNF therapy as model.Pharmacovigilance in oncology: evaluation of current practice and future perspectives.Trends of reporting of 'serious'vs. 'non-serious' adverse drug reactions over time: a study in the French PharmacoVigilance Database.Rhabdomyolysis a result of azithromycin and statins: an unrecognized interactionMethods for observational post-licensure medical product safety surveillance.Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBase.Comparison of statistical signal detection methods within and across spontaneous reporting databases.Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001 - 2012.Methods for retrospective detection of drug safety signals and adverse events in electronic general practice records.Prescribing patterns and safety monitoring of duloxetine using the Danish Register of Medicinal Product Statistics as a source.Outlier removal to uncover patterns in adverse drug reaction surveillance - a simple unmasking strategy.Concomitant medications and obstructive sleep apnoea.Statins and diabetes: is there any difference between the different statins?Prescribed drugs and violence: a case/noncase study in the French PharmacoVigilance Database.A comparative study of QT prolongation with serotonin reuptake inhibitors.
P2860
Q28477448-D1D5A45A-5341-437D-A012-04EFE4470720Q34381361-F01A6E5E-86A2-4429-9F19-9DAECA6F4B61Q34572340-10B58739-FF03-40D8-9DA4-B1AFC1C8BB45Q35183601-C7A92308-424C-46C7-B046-5E55DCD480C4Q36088026-3B81E295-E014-4C09-A7EA-8C48BF31572CQ37397811-738FE21D-0137-42FF-89E1-26D18EF2CAE9Q37964440-D3057BE3-AB2B-4849-85F5-CE59B28F55C2Q38661018-3ED5C329-DB5C-47E3-93D8-B23A4E7E9154Q41032717-5BF8E2E5-1B8E-452B-BB71-05E08F1BCE00Q44280390-A1DE6A61-76D4-4B2D-94A7-58E93B08E390Q44301592-CACEF20E-630C-469D-8AA4-EC909AAA4D6DQ44563910-DA500427-A670-475E-A7E6-43DC1C6FA462Q45805539-DACCCFCE-FEA7-4632-9374-C35F1FC796D7Q47713038-886CCC7E-F85E-430D-B11D-EB2D7DC71040Q48261639-35CB781A-8A94-4FE4-9BBC-16B9B493B983Q50556141-D9CE68EC-9E9F-47B2-B02B-8618407FBD69Q53811350-0F82AE6B-8064-4540-BD07-A0370AFCB6F2
P2860
The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The application of knowledge d ...... : example of the WHO database.
@en
The application of knowledge d ...... : example of the WHO database.
@nl
type
label
The application of knowledge d ...... : example of the WHO database.
@en
The application of knowledge d ...... : example of the WHO database.
@nl
prefLabel
The application of knowledge d ...... : example of the WHO database.
@en
The application of knowledge d ...... : example of the WHO database.
@nl
P2093
P2860
P1476
The application of knowledge d ...... : example of the WHO database.
@en
P2093
P2860
P304
P356
10.1111/J.1472-8206.2007.00552.X
P577
2008-02-01T00:00:00Z